Brief: Gensight Biologics End-Dec Cash And Cash Equivalents At 37.9 Million Euros

Gensight Biologics SA

19/01/2021 06:37

Jan 19 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS REPORTS CASH POSITION AS OF DECEMBER
31, 2020
AND PROVIDES OPERATIONAL UPDATE
    * CASH AND CASH EQUIVALENTS TOTALED EUR 37.9 MILLION AS OF
DECEMBER 31, 2020, COMPARED TO EUR 18.1 MILLION AS OF SEPTEMBER
30, 2020
    * OPERATING CASH BURN WAS MORE THAN OFFSET BY NET PROCEEDS
FROM
EUR 25 MILLION PRIVATE PLACEMENT IN OCTOBER LED BY ARIX
BIOSCIENCE, INVUS AND SOFINNOVA PARTNERS

Source text for Eikon:  ID:nBw14kD5la 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))